Company Search:
Advanced Search
Sponsored Links
Response Genetics, Inc. Company Snapshot
Response Genetics, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Response Genetics with three other companies in this sector in UNITED STATES : Corgenix Medical Corporation (2014 sales of $11.01 million of which 100% was Diagnostic Products), Immunomedics, Inc. ($9.04 million of which 100% was Biopharma Products), and Avid Bioservices Inc ($22.40 million of which 100% was Contract Manufacturing and Development o).

Sales Analysis. During the year ended December of 2014, sales at Response Genetics were $16.72 million. This is a decrease of 15.6% versus 2013, when the company's sales were $19.80 million.
  Stock Performance Chart for Response Genetics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .00
(Figures in U.S. Dollars)
1 Week 42.9%   13 Weeks 20.0%  
4 Weeks 26.6%   52 Weeks -40.0%  
Response Genetics, Inc. Key Data:
  Ticker: RGDXQ Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2014 Sales 16,720,327
(Year Ending Jan 2015).
Employees: 100
  Currency: U.S. Dollars Market Cap: 116,386
  Fiscal Yr Ends: December Shares Outstanding: 38,795,396
  Share Type: Common Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.